| Characteristic |
Aerobic Exercise (n=29) |
Electro-Acupuncture (n=27) |
Combination Therapy (n=30) |
Control (n=26) |
| Age (years) |
61.4 ± 8.9 |
63.0 ± 9.1 |
63.1 ± 8.8 |
62.3 ± 8.7 |
| Gender (male/female) |
17/12 |
17/10 |
19/11 |
16/10 |
| Time since CHD diagnosis (month) |
20.6 ± 9.3 |
19.2 ± 8.0 |
20.5 ± 9.1 |
21.1 ± 9.2 |
| Gensini grade |
11 (37.9%) |
9 (33.3%) |
10 (33.3%) |
9 (34.6%) |
| BMI (kg/m2) |
25.42 ± 3.92 |
24.87 ± 4.01 |
25.36 ± 3.95 |
24.63 ± 3.91 |
| After PCI |
11 (37.9%) |
9 (33.3%) |
10 (33.3%) |
9 34.6%) |
| After CABG |
2 (6.9%) |
2 (7.4%) |
2 (6.7%) |
2 (7.7%) |
| Smoke |
15 (51.7%) |
13 (48.1%) |
14 (46.7%) |
12 (46.2%) |
| Hypertension |
21 (72.4%) |
20 (74.1%) |
21 (70.0%) |
20 (76.9%) |
| Diabetes |
10 (34.5%) |
8 (29.6%) |
9 (30.0%) |
8 (30.8%) |
| Hyperlipidemia |
11 (37.9%) |
10 (37.0%) |
11 (36.7%) |
10 (38.5%) |
| Prescriptions |
| β-blocker |
24 (82.8%) |
22 (81.5%) |
23 (76.7%) |
22 (84.6%) |
| Antiplatelets |
28 (96.6%) |
27 (100%) |
29 (96.7%) |
25 (96.2%) |
| Statins |
29 (100%) |
27 (100%) |
30 (100%) |
26 (100%) |
| Nitrates |
10 (34.5%) |
7 (25.9%) |
11 (36.7%) |
8 (30.8%) |
| ACEI/ARB |
27 (93.1%) |
25 (92.6%) |
28 (93.3%) |
24 (92.3%) |
|
